natgillin/translations-raw huggingface dataset:
Pleuraekssudat5, faryngolaryngeale smerter, pharyngitis Pleuralgi, lungefibrose, pulmonal hypertension, pulmonal blødning respirationssvigt11*, interstitiel lungesygdom* Kvalme, diarré, opkast, dyspepsi, abdominalsmerter6 
Respiratory, thoracic and mediastinal disorders Pleural effusion5, pharyngolaryngeal pain, pharyngitis Pleuritic pain, pulmonary fibrosis, pulmonary hypertension, pulmonary Acute respiratory failure11*, interstitial lung disease* Nausea, diarrhoea, vomiting, dyspepsia, abdominal pain6
- Muskelkramper eller led-, muskel- eller knoglesmerter, mens du er i behandling med Imatinib 
• Muscle cramps or joint, muscle or bone pain, during treatment with Imatinib Teva B.V. or after you have stopped taking Imatinib Teva B.V.
(1 time) dag 4-5; i.v. 
(1 h) days 4-5;
Der sås 4. grads neutropeni (ANC <0,5 x 109/l) og trombopeni (trombocyttal <10 x 109/l) hos henholdsvis 3,6% og <1% af patienterne med nydiagnosticeret CML i kronisk fase. 
In newly diagnosed chronic phase CML grade 4 neutropenia (ANC < 0.5 x 109/l) and thrombocytopenia (platelet count < 10 x 109/l) were observed in 3.6% and < 1% of patients, respectively.
MTX 15 mg intrathecal, dag 1; 
MTX 12 mg intrathecal, day 1
Fra tilgængelige sikkerhedsdata ser det ikke ud til, at sikkerhedsprofilen for imatinib ændres ved optrapning af dosis til 800 mg daglig til patienter, hvis sygdom fremskrider ved de lavere doser på 400 mg eller 600 mg daglig. 
From the safety data available, escalating the dose to 800 mg daily in patients progressing at lower doses of 400 mg or 600 mg daily does not seem to affect the safety profile of imatinib.
(24 timer), dag 4; DEX 40 mg/dag på dag 1-4 og 11-14, supplerende med MTX 1 g/m2 
DEX 40 mg/day on days 1-4 and 11-14, alternated with MTX 1 g/m2 i.v.
Samtidig anvendelse af imatinib og lægemidler, der inducerer CYP3A4 (f.eks. dexamethason, phenytoin, carbamazepin, rifampicin, phenobarbital eller Hypericum perforatum, også kendt som prikbladet perikum) kan signifikant reducere følsomheden over for imatinib og dermed potentielt øge risikoen for terapeutisk svigt. 
Concomitant use of imatinib and medicinal products that induce CYP3A4 (e.g. dexamethasone, phenytoin, carbamazepine, rifampicin, phenobarbital or Hypericum perforatum, also known as St. John's Wort) may significantly reduce exposure to imatinib, potentially increasing the risk of therapeutic failure.
ul. 
GIST.
er nødvendig, skal overvåges tæt for tegn og symptomer på aktiv HBV-infektion i hele behandlingsperioden og i flere måneder efter behandlingsophør (se pkt. 
Carriers of HBV who require treatment with Imatinib Teva B.V. should be closely monitored for signs and symptoms of active HBV infection throughout therapy and for several months following termination of therapy (see section 4.8).
Kronisk myeloid leukæmi er en type leukæmi, hvor nogle bestemte unormale hvide blodlegemer (der kaldes myeloide 
Chronic myeloid leukaemia is a form of leukaemia in which certain abnormal white cells (named myeloid cells) start growing out of control.
Hvis noget af det ovenstående gælder for dig, skal du fortælle din læge det, før du tager Imatinib 
If any of these apply to you, tell your doctor before taking Imatinib Teva B.V.
L-ASP (6.000 IE/m2, i.m. 
L-ASP (6000 IUnits/m2, IM): day 44
Dosisjusteringer på grund af neutropeni og trombocytopeni 
Dose adjustments for neutropenia and thrombocytopenia:
Ara-C 40 mg intrathecal, dag 1, 8, 15, 22; 
Ara-C 40 mg intrathecal, days 1, 8, 15, 22;
Samtidig anvendelse af stærke CYP3A4 induktorer og imatinib bør 
Therefore, concomitant use of strong CYP3A4 inducers and imatinib should be avoided (see section 4.5).
Pliva Hrvatska d.o.o. 
PLIVA Croatia Ltd.
Der anbefales en dosis på 340 mg/m2 
(starting dose 340 mg/m2)
(24 timer), dag 1, og Ara-C 2 g/m i.v. 
(24 h), day 1, and Ara-C 2 g/m2 i.v.
Lægen vil fortælle dig, hvor mange Imatinib Teva B.V.-tabletter, du skal give dit barn. 
The doctor will tell you how many tablets of Imatinib Teva B.V. to give to your child.
Din læge vil fortælle dig, præcis hvor mange Imatinib Teva B.V.-tabletter, du skal tage. 
Your doctor will tell you exactly how many tablets of Imatinib Teva B.V. to take.
MTX 15 mg intrathecal, dag 1, 8, 15, 22; 
MTX 15 mg intrathecal, days 1, 8, 15, 22;
Hvis cytopeni vedvarer i 2 uger, reducer dosis yderligere til 300 mg. 4. 
If cytopenia persists for 2 weeks, reduce further to 300 mg. 4.
Hvornår og hvordan skal du tage Imatinib Teva B.V. 
When and how to take Imatinib Teva B.V. - Take Imatinib Teva B.V. with a meal.
Brug af anden medicin sammen med Imatinib Teva B.V. 
Other medicines and Imatinib Teva B.V.
Lægen vil fortælle dig, hvor mange Imatinib Teva B.V.-kapsler, du skal give dit barn. 
The doctor will tell you how many capsules of Imatinib Teva B.V. to give to your child.
Hvis din daglige dosis er 800 mg (8 tabletter), skal du tage 4 tabletter om morgenen og 4 tabletter om aftenen. 
If your daily dose is 800 mg (8 tablets), you should take 4 tablets in the morning and 4 tablets in
Spor af de opløste tabletter 
Traces of the dissolved tablets may be left behind in the glass.
Pustuløst udslæt, kontusion, øget svedtendens, urticaria, ecchymose, let til knubs og mærker, hypotrichosis, hypopigmentering af huden, dermatitis exfoliativa, onychoclasi, folliculitis, petechier, psoriasis, purpura, hyperpigmentering af huden, bulløst udslæt Akut febril neutrofil dermatose (Sweets syndrom), misfarvning af negle, angioødem, vesikulært udslæt, erythema multiforme, leukocytoklastisk vasculitis, Stevens-Johnson syndrom, akut generaliseret eksantematøs 
Rash pustular, contusion, sweating increased, urticaria, ecchymosis, increased tendency to bruise, hypotrichosis, skin hypopigmentation, dermatitis exfoliative, onychoclasis, folliculitis, petechiae, psoriasis, purpura, skin hyperpigmentation, bullous eruptions Acute febrile neutrophilic dermatosis (Sweet's syndrome), nail discolouration, angioneurotic oedema, rash vesicular, erythema multiforme, leucocytoclastic vasculitis, Stevens-Johnson syndrome, acute generalised exanthematous pustulosis (AGEP) Palmoplantar erythrodysesthesia syndrome*, lichenoid keratosis*, lichen planus*, toxic epidermal necrolysis*, drug rash with eosinophilia and
daglig til børn med Ph+ ALL (totaldosis på 600 mg må ikke overskrides). 
The dose of 340 mg/m2 daily is recommended for children with Ph+ ALL (not to exceed the total dose of 600 mg).
G-CSF (5 μg/kg, s.c.): dag 27-36, eller indtil ANC >1500 post nadir ARA-C (3 g/m2, q 12 timer, i.v. 
G-CSF (5 μg/kg, SC): days 27-36 or until ANC > 1500 post nadir ARA-C (3 g/m2, q12h, IV): days 43, 44
Anafylaktisk shock* 
Anaphylactic shock* Blood and lymphatic system disorders
Din læge vil fortælle dig, præcis hvor mange Imatinib Teva B.V.-kapsler, du skal tage. 
Your doctor will tell you exactly how many capsules of Imatinib Teva B.V. to take.
Farmakokinetik hos GIST-patienter 
Pharmacokinetics in children
1Hæmatologiske responskriterier (hvert respons skal bekræftes ≥4 uger): CHR: Undersøgelse 0102 [ANC ≥1,5 x 109/l, trombocytter ≥100 x 109/l, ingen blaster i blodet, BM 
CHR: In study 0102 [ANC ≥ 1.5 x 109/l, platelets ≥ 100 x 109/l, no blood blasts, BM blasts < 5%
100 mg filmovertrukne tabletter Pakningsstørrelser indeholdende 60 eller 120 filmovertrukne tabletter i blisterpakninger. 
Imatinib Teva B.V. 100 mg film-coated tablets Pack sizes of 60 or 120 film-coated tablets in blisters.
DEX 10 mg/m2 oral, dag 1-5; CP 200 mg/m i.v., dag 3, 4, 5; MTX 12 mg intrathecal, dag 1 
DEX 10 mg/m2 oral, days 1-5; CP 200 mg/m2 i.v., days 3, 4, 5;
Pakningsstørrelser indeholdende 20x1, 60x1, 120x1 eller 180x1 filmovertrukne tabletter i perforeret 
Pack sizes of 20x1, 60x1, 120x1 or 180x1 film-coated tablets in perforated unit dose blisters.
Hvis du ved et uheld har indtaget for mange tabletter, skal du kontakte din læge med det samme. 
If you take more Imatinib Teva B.V. than you should If you have accidentally taken too many tablets, talk to your doctor straight away.
Hvis du ved et uheld har indtaget for mange kapsler, skal du kontakte din læge med det samme. 
If you take more Imatinib Teva B.V. than you should If you have accidentally taken too many capsules, talk to your doctor straight away.
100 mg hårde kapsler fås i blisterpakninger med 60 eller 120 hårde kapsler. 
Imatinib Teva B.V. 100 mg hard capsules are available in pack sizes of 60 or 120 hard capsules in blisters.
er 100 mg/dag til voksne patienter med HES/CEL. 
The recommended dose of Imatinib Teva B.V. is 100 mg/day for adult patients with HES/CEL.
- Hvis du behandles for Ph-positiv ALL: Startdosis er 600 mg, som skal tages som 6 kapsler én gang daglig. 
- If you are being treated for Ph-positive ALL: The starting dose is 600 mg to be taken as 6 capsules once a day.
Alderen på disse patienter rangerede fra 2 til 16 år, og imatinib blev givet i en dosis på 300 mg/m2 dagligt eller doser, 
The age of these patients ranged from 2 to 16 years and imatinib was given at dose 300 mg/m2 daily or doses ranging from 200 to 400
- Hvis du glemmer at tage en dosis, så tag den, så snart du kommer i tanker om det. 
If you forget to take Imatinib Teva B.V. - If you forget a dose, take it as soon as you remember.
- Hvis du behandles for Ph-positiv ALL: Startdosis er 600 mg, som skal tages som 6 tabletter én gang daglig. 
- If you are being treated for Ph-positive ALL: The starting dose is 600 mg to be taken as 6 tablets once a day.
Spørg lægen, apotekspersonalet eller sundhedspersonalet, hvis der er noget, du er i tvivl om. 
Check with your doctor or pharmacist if you are
Pakningsstørrelser indeholdende 20x1, 60x1, 120x1 eller 180x1 hårde kapsler i perforeret 
Pack sizes of 20x1, 60x1, 120x1 or 180x1 hard capsules in perforated unit dose blisters.
Imatinib farmakokinetik 
Population pharmacokinetics
ARA-C (3 g/m2/dosis q 12 timer x 4, i.v. 
ARA-C (3 g/m2/dose q 12 h x 4, IV): days 2 and 3
Afvigelser i laboratorieværdier 
Liver function tests
(1 time) dag 1; Ara-C 60 mg/m2 i.v., dag 22-25, 29-32 Konsoliderende behandling I, III, V MTX 500 mg/m2 i.v. 
(24 h), days 1, 15; 6-MP 25 mg/m2 oral, days 1-20 Consolidation therapy II, IV Ara-C 75 mg/m2 i.v.
Hvis din daglige dosis er 800 mg (2 tabletter), skal du tage 1 tablet om morgenen og 1 tablet om aftenen. 
If your daily dose is 800 mg (2 tablets), you should take one tablet in the morning and a second
400 mg filmovertrukne tabletter Pakningsstørrelser indeholdende 30 eller 90 filmovertrukne tabletter i blisterpakninger. 
Imatinib Teva B.V. 400 mg film-coated tablets Pack sizes of 30 or 90 film-coated tablets in blisters.
Hvis cytopeni ikke er leukæmirelateret, reducer imatinib-dosis til 260 mg/m 3. 
If cytopenia is unrelated to leukaemia, reduce dose of imatinib to 260 mg/m 3.
Den filmovertrukne tablet har en længde på ca. 20 mm og en vidde på ca. 10 mm. Imatinib Teva B.V. 
The length of the film-coated tablet is approximately 20 mm and the width is approximately 10 mm.
100 mg filmovertrukne tabletter fås i perforerede enkeltdosisblisterpakninger med 20x1, 60x1, 120x1 eller 180x1 filmovertrukne tabletter. 
Imatinib Teva B.V. 100 mg film-coated tablets are available in pack sizes of 20x1, 60x1, 120x1 or 180x1 film-coated tablets in perforated unit dose blisters.
- Kraftige mavesmerter, blod i opkast, afføring eller urin, sortfarvet afføring (tegn på mave-tarm 
• Severe abdominal pain, blood in your vomit, stools or urine, black stools (signs of gastrointestinal disorders).
(24 timer), dag 1, 15; oral, dag 1-20 
(24 h), days 1, 15; 6-MP 25 mg/m2 oral, days 1-20
400 mg hårde kapsler fås i blisterpakninger med 30 eller 90 hårde kapsler. 
Imatinib Teva B.V. 400 mg hard capsules are available in pack sizes of 30 or 90 hard capsules in blisters.
Pakningsstørrelser indeholdende 30x1 eller 90x1 filmovertrukne tabletter i perforeret 
Pack sizes of 30x1 or 90x1 film-coated tablets in perforated unit dose blisters.
beregnet til brug i den mest fremskredne fase af sygdommen (blastkrise). 
In adult patients, Imatinib Teva B.V. is intended for use in the most advanced phase of the disease (blast crisis).
Den sædvanlige startdosis er 600 mg, som skal tages som 1 tablet a 400 mg og 2 tabletter a 
The usual starting dose is 600 mg to be taken as one tablet of 400 mg plus 2 tablets of 100 mg once a
Ikke-transparent orange kapsel præget i sort blæk med 7629 på kapselbunden og præget i sort blæk med TEVA på kapselhætten. 
Non transparent orange capsules with black marking 7629 on capsule body and black marking TEVA on capsule cap.
G-CSF (5 μg/kg, s.c.): dag 4-13, eller indtil ANC >1500 post nadir VCR (1,5 mg/m2/dag, i.v. 
G-CSF (5 μg/kg, SC): days 4-13 or until ANC > 1500 post nadir VCR (1.5 mg/m2/day, IV): days 1, 8, and 15
CPM (250 mg/m2/dosis q12 timer x 4 doser, i.v. 
CPM (250 mg/m2/dose q12h x 4 doses, iv): Days 3 and 4
Akut febril neutrofil dermatose (Sweets syndrom), misfarvning af negle, angioødem, vesikulært udslæt, erythema multiforme, leukocytoklastisk vasculitis, Stevens-Johnson syndrom, akut generaliseret eksantematøs 
Acute febrile neutrophilic dermatosis (Sweet's syndrome), nail discolouration, angioneurotic oedema, rash vesicular, erythema multiforme, leucocytoclastic vasculitis, Stevens-Johnson syndrome, acute generalised exanthematous pustulosis (AGEP) Palmoplantar erythrodysesthesia syndrome*, lichenoid keratosis*, lichen planus*, toxic epidermal necrolysis*, drug rash with eosinophilia and
- Kvalme opkastninger, diarré eller fordøjelsesbesvær. 
• Feeling sick (nausea), being sick (vomiting), diarrhoea or indigestion.
Den sædvanlige startdosis er 600 mg, som skal tages som 1 kapsel a 400 mg og 2 kapsler a 
The usual starting dose is 600 mg to be taken as one capsule of 400 mg plus 2 capsules of 100 mg
Hvis din daglige dosis er 800 mg (8 kapsler), skal du tage 4 kapsler om morgenen og 4 kapsler om aftenen. 
If your daily dose is 800 mg (8 capsules), you should take 4 capsules in the morning and 4
Startdosis er 100 mg, som skal tages som 1 tablet a 100 mg én gang daglig. 
The starting dose is 100 mg, to be taken as one tablet of 100 mg once a day.
Startdosis er 100 mg, som skal tages som 1 kapsel a 100 mg én gang daglig. 
The starting dose is 100 mg, to be taken as one capsule of 100 mg once a day.
100 mg hårde kapsler Imatinib Teva B.V. 
NAME OF THE MEDICINAL PRODUCT Imatinib Teva B.V. 100 mg hard capsules Imatinib Teva B.V. 400 mg hard capsules
400 mg hårde kapsler er uigennemsigtige orange kapsler, præget med 7630 med sort trykfarve på kapslens underdel og præget med TEVA på kapslens overdel. 
Imatinib Teva B.V. 400 mg hard capsules are non-transparent orange capsules with black marking 7630 on capsule body and black marking TEVA on capsule cap.
er 400 mg/dag til voksne patienter med inoperable 
The recommended dose of Imatinib Teva B.V. is 400 mg/day for adult patients with unresectable and/or
Hvis din daglige dosis er 800 mg (2 kapsler), skal du tage 1 kapsel om morgenen og 1 kapsel om aftenen. 
If your daily dose is 800 mg (2 capsules), you should take one capsule in the morning and a
Ikke-transparent orange kapsel præget i sort blæk med 7630 på kapselbunden og præget i sort blæk med TEVA på kapselhætten. 
Non transparent orange capsules with black marking 7630 on capsule body and black marking TEVA on capsule cap.
Hvis cytopeni ikke er leukæmirelateret, reducer imatinib-dosis til 400 mg. 3. 
If cytopenia is unrelated to leukaemia, reduce dose of imatinib to 400 mg. 3.
400 mg filmovertrukne tabletter Hver filmovertrukken tablet indeholder 400 mg imatinib (som mesilat). 
Imatinib Teva B.V. 400 mg film-coated tablets Each film-coated tablet contains 400 mg of imatinib (as mesilate).
(2 timer, q 12 timer), dag 23 (total af 8 omgange) 
2-3 (total of 8 courses)
100 mg hårde kapsler er uigennemsigtige orange kapsler, præget med 7629 med sort trykfarve på kapslens underdel og præget med TEVA på kapslens overdel. 
Imatinib Teva B.V. 100 mg hard capsules are non-transparent orange capsules with black marking 7629 on capsule body and black marking TEVA on capsule cap.
Stomatitis, mundulcera, gastrointestinalblødning7, sure opstød, melæna, betændelse i spiserøret, ascites, mavesår, hæmatemese, cheilitis, dysfagi, 
Stomatitis, mouth ulceration, gastrointestinal haemorrhage7, eructation, melaena, oesophagitis, ascites, gastric ulcer, haematemesis, cheilitis,
100 mg filmovertrukne tabletter Hver filmovertrukken tablet indeholder 100 mg imatinib (som mesilat). 
Imatinib Teva B.V. 100 mg film-coated tablets Each film-coated tablet contains 100 mg of imatinib (as mesilate).
Din læge kan beslutte at øge dosis til 400 mg, som skal tages som 1 kapsel a 400 mg én gang daglig afhængig af, hvordan du responderer på behandlingen. 
Your doctor may decide to increase the dose to 400 mg, to be taken as one capsule of 400 mg once a day, depending on how you respond to treatment.
100 mg hårde kapsler fås i perforerede enkeltdosisblisterpakninger med 20x1, 60x1, 120x1 eller 180x1 hårde kapsler. 
Imatinib Teva B.V. 100 mg hard capsules are available in pack sizes of 20x1, 60x1, 120x1 or 180x1 hard capsules in perforated unit dose blisters.
Konsoliderende behandling II, IV Ara-C 75 mg/m i.v. 
Consolidation therapy I, III, V MTX 500 mg/m i.v.
Periorbitalt ødem, dermatitis/eksem/udslæt Pruritus, ansigtsødem, tør hud, erythem, alopeci, natlig svedtendens, 
Hepatic failure8, hepatic necrosis Skin and subcutaneous tissue disorders Periorbital oedema, dermatitis/eczema/rash Pruritus, face oedema, dry skin, erythema, alopecia, night sweats,
ANC = fuldstændigt antal neutrofilocytter a opstået efter mindst 1 måneds behandling 
a occurring at least after 1 month of treatment
Methylprednisolon 40 mg intrathecal, dag 1 
MTX 15 mg intrathecal, day 1; Methylprednisolone 40 mg intrathecal, day 1
100 mg filmovertrukne tabletter er mørkegule til brunlig-orange runde filmovertrukne tabletter med delekærv på den ene side. 
Imatinib Teva B.V. 100 mg film-coated tablets are dark yellow to brownish orange round film-coated tablets with a score line on one side.
Din læge kan beslutte at øge dosis til 400 mg, som skal tages som 1 tablet a 400 mg én gang daglig afhængig af, hvordan du responderer på behandlingen. 
Your doctor may decide to increase the dose to 400 mg, to be taken as one tablet of 400 mg once a day, depending on how you respond to treatment.
Startdosis er 400 mg, som skal tages som 1 kapsel én gang daglig. 
The starting dose is 400 mg, to be taken as one capsule once a day.
hård kapsel indeholder 100 mg imatinib (som mesilat). 
Each hard capsule contains 100 mg of imatinib (as mesilate).
I tilfælde af svær neutropeni og trombocytopeni anbefales dosisreduktion eller seponering af behandlingen, som angivet i nedenstående tabel: 
Dose reduction or treatment interruption for severe neutropenia and thrombocytopenia are recommended as
B. BETINGELSER ELLER BEGRÆNSNINGER VEDRØRENDE UDLEVERING OG 
MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND
hæmmer væksten af disse celler i en vis undergruppe af disse sygdomme. 
Imatinib Teva B.V. inhibits the growth of these cells in a certain subtype of these diseases.
Hos ca. 2,5% af nyligt diagnosticerede CML-patienter i behandling med imatinib er der rapporteret tilfælde af svær væskeretention (pleuraeksudat, ødem, pulmonalt ødem, ascites, perifert ødem). 
Occurrences of severe fluid retention (pleural effusion, oedema, pulmonary oedema, ascites, superficial oedema) have been reported in approximately 2.5% of newly diagnosed CML patients taking imatinib.
filovertrukken tablet indeholder 100 mg imatinib (som mesilat). 
Each film-coated tablet contains 100 mg of imatinib (as mesilate).
2/dag, p.o.): dag 1-56 
2/day, PO): days 1-7 and 15-21
hård kapsel indeholder 400 mg imatinib (som mesilat). 
Each hard capsule contains 400 mg of imatinib (as mesilate).
): dag 1, 8, og 15 
i.v., days 1, 8;
Kaplan-Meier estimatet for overlevelse efter 36 
The Kaplan-Meier estimate for survival after 36-month follow-up is 68%.
Hrvatska 
RFS
- Kvalme, åndenød, uregelmæssig hjerterytme (puls), uklar urin, træthed og/eller ubehag forbundet med abnorme resultater af laboratorieprøver (f.eks. højt indhold af kalium, urinsyre og calcium i blodet og lavt indhold af fosfor i blodet). 
• Nausea, shortness of breath, irregular heartbeat, clouding of urine, tiredness and/or joint discomfort associated with abnormal laboratory test results (eg.
Delvist 
Headache2
Startdosis er 400 mg, som skal tages som 1 tablet én gang daglig. 
The starting dose is 400 mg, to be taken as one tablet once a day.
400 mg filmovertrukne tabletter imatinib 
Imatinib Teva B.V. 400 mg film-coated tablets
100 mg filmovertrukne tabletter 
Imatinib Teva B.V. 100 mg film-coated tablets
United Kingdom 
Czech Republic
Gennem alle faser af omsorgen bør behandlingen overvåges af hæmatologiske eksperter, som er 
Haematological experts in the management of this disease should supervise the therapy throughout all phases
Gynækomasti, erektil dysfunktion, menoragi, uregelmæssig menstruation, seksuel dysfunktion, smerter i brystvorterne, brystforstørrelse, skrotalt Hæmoragisk corpus luteum/hæmoragisk ovariecyste Almene symptomer og reaktioner på administrationsstedet Svaghed, pyreksi, anasarka, kuldegysninger og kulderystelser 
Muscular weakness, arthritis, rhabdomyolysis/myopathy Avascular necrosis/hip necrosis*, growth retardation in children* Renal pain, haematuria, renal failure acute, urinary frequency increased Reproductive system and breast disorders Gynaecomastia, erectile dysfunction, menorrhagia, menstruation irregular, sexual dysfunction, nipple pain, breast enlargement, scrotal Haemorrhagic corpus luteum/haemorrhagic ovarian cyst General disorders and administration site conditions Weakness, pyrexia, anasarca, chills, rigors
I dyremodeller, hvor der anvendes Bcr-Abl-positive tumorceller, har stoffet som enkeltstof in vivo 
In vivo the compound shows anti-tumour activity as a single agent in animal models using Bcr-Abl positive
Hvis cytopeni ikke er leukæmirelateret, reducer imatinib-dosis til 400 mg. 7. 
If cytopenia is unrelated to leukaemia, reduce dose of imatinib to 400 mg.
Leucovorin (75 mg/m2 i time 36, i.v. 
Leucovorin (75 mg/m2 at hour 36, IV; 15 mg/m2 IV or PO q6h x 6
som er forbundet med platelet-derived growth factor receptor-omlejring (PDGFR-omlejring). 
• Adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with platelet derived growth factor receptor (PDGFR) gene re-arrangements.
18 Gy i 10 fraktioner for patienter, som er CNS3 ved diagnosticering VCR (1,5 mg/m2/dag, i.v. 
18 Gy in 10 fractions for patients that are CNS3 at diagnosis
100 mg filmovertrukne tabletter Imatinib Teva B.V. 
NAME OF THE MEDICINAL PRODUCT Imatinib Teva B.V. 100 mg film-coated tablets Imatinib Teva B.V. 400 mg film-coated tablets
Hud og subkutane væv Meget almindelig: 
Hepatic failure8, hepatic necrosis Skin and subcutaneous tissue disorders Very common:
Forsigtighed bør udvises, når imatinib administreres sammen 
Caution should be taken when administering imatinib with inhibitors of the CYP3A4
filmovertrukkentablet indeholder 400 mg imatinib (som mesilat). 
Each film-coated tablet contains 400 mg of imatinib (as mesilate).
5 Pleural effusion blev observeret oftere hos patienter med GIST og hos patienter med transformeret CML (CML-AP og CML-BC) end hos patienter med kronisk CML. 
CML (CML-AP and CML-BC) than in patients with chronic CML.
100 mg hårde kapsler Hver hård kapsel indeholder 100 mg imatinib (som mesilat). 
Imatinib Teva B.V. 100 mg hard capsules Each hard capsule contains 100 mg of imatinib (as mesilate).
oral, dag 1-5; i.v., dag 6-7, 13-14 i.v. 
Daunorubicin 45 mg/m2 i.v., days 6-7, 13-14
er 800 mg/dag til voksne patienter med DSFP. 
The recommended dose of Imatinib Teva B.V. is 800 mg/day for adult patients with DFSP.
400 mg hårde kapsler Hver hård kapsel indeholder 400 mg imatinib (som mesilat). 
Imatinib Teva B.V. 400 mg hard capsules Each hard capsule contains 400 mg of imatinib (as mesilate).
; 15 mg/m2 i.v. 
Ara-C 75 mg/m2 i.v.
400 mg hårde kapsler 
imatinib teva b.v. 400 mg hard capsules
Din læge kan beslutte at øge dosis til 400 mg, som skal tages som 4 tabletter én gang daglig afhængig af, hvordan du 
Your doctor may decide to increase the dose to 400 mg, to be taken as 4 tablets once a day, depending on how you respond to treatment.